475 related articles for article (PubMed ID: 33012318)
1. Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.
Eschenbacher W; Straesser M; Knoeddler A; Li RC; Borish L
Immunol Allergy Clin North Am; 2020 Nov; 40(4):539-547. PubMed ID: 33012318
[TBL] [Abstract][Full Text] [Related]
2. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
3. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
4. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
5. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma.
Lombardo N; Pelaia C; Ciriolo M; Della Corte M; Piazzetta G; Lobello N; Viola P; Pelaia G
Int J Immunopathol Pharmacol; 2020; 34():2058738420950851. PubMed ID: 32816558
[TBL] [Abstract][Full Text] [Related]
6. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
Kramer MF; Ostertag P; Pfrogner E; Rasp G
Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
[TBL] [Abstract][Full Text] [Related]
7. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibodies for the Treatment of Nasal Polyps.
Willson TJ; Naclerio RM; Lee SE
Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
[TBL] [Abstract][Full Text] [Related]
9. Biologics in allergic rhinitis.
Bayar Muluk N; Cingi C
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):43-52. PubMed ID: 37869947
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Dupilumab.
Harb H; Chatila TA
Clin Exp Allergy; 2020 Jan; 50(1):5-14. PubMed ID: 31505066
[TBL] [Abstract][Full Text] [Related]
11. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
12. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
Brown WC; Senior B
Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
[TBL] [Abstract][Full Text] [Related]
13. Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases.
Cox L
Immunol Allergy Clin North Am; 2020 Nov; 40(4):687-700. PubMed ID: 33012328
[TBL] [Abstract][Full Text] [Related]
14. Updates on current evidence for biologics in chronic rhinosinusitis.
Nasta MS; Chatzinakis VA; Georgalas CC
Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):18-24. PubMed ID: 31789925
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
Agarwal A; Spath D; Sherris DA; Kita H; Ponikau JU
Clin Rev Allergy Immunol; 2020 Oct; 59(2):141-149. PubMed ID: 31073812
[TBL] [Abstract][Full Text] [Related]
17. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
Rivero A; Liang J
Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
[TBL] [Abstract][Full Text] [Related]
18. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
Striz I; Golebski K; Strizova Z; Loukides S; Bakakos P; Hanania NA; Jesenak M; Diamant Z
Clin Sci (Lond); 2023 May; 137(9):727-753. PubMed ID: 37199256
[TBL] [Abstract][Full Text] [Related]
19. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
Nagase H; Ueki S; Fujieda S
Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis.
Licari A; Castagnoli R; De Filippo M; Foiadelli T; Tosca MA; Marseglia GL; Ciprandi G
Expert Opin Biol Ther; 2020 Jun; 20(6):609-619. PubMed ID: 32053391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
